Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)
25.55
+0.85 (3.44%)
At close: Jan 19, 2026
Shanghai Serum Bio-Technology Company Description
Shanghai Serum Bio-Technology Co., Ltd. engages in the research, development, production, operation, and sales of antitoxin and antiserum products in China.
It offers equine anti-tetanus immunoglobulin, anti-venin, and anti-rabies serum products. The company was founded in 1999 and is based in Shanghai, China.
Shanghai Serum Bio-Technology Co., Ltd.
| Country | China |
| Founded | 1999 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 324 |
| CEO | Tiejiong Fan |
Contact Details
Address: No. 1288, Huaqing Road Shanghai, 201707 China | |
| Phone | 86 21 6076 0783 |
| Website | serum-china.com.cn |
Stock Details
| Ticker Symbol | 688163 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Tiejiong Fan | GM and Director |
| Liangjun Peng | Deputy GM, Core Technical Personnel and Director |
| Qiong Cheng | Deputy GM, Board Secretary and Director |
| Zhiping Zhang | Assistant to GM and Core Technical Personnel |
| Hao Zhang | General Manager Assistant |
| Jin Bao Liu | Financial Director |
| Binsheng Chen | Accounting Supervisor |